BioCryst Pharmaceuticals, Inc.BCRXNASDAQ
Loading
Stockholders Equity Over TimeExpanding
Percentile Rank71
Studio
Year-over-Year Change

Net worth of the company (assets minus liabilities)

Latest
$-119.15M
↑ 65% vs avg
Percentile
P71
Within normal range
Streak
1 yr
Consecutive growthExpanding
Average
$-336.31M
Historical baseline
PeriodValueYoY Change
2025$-119.15M+75.0%
2024$-475.93M-4.5%
2023$-455.53M-54.6%
2022$-294.60M-175.4%
2021$-106.99M-455.4%
2020$-19.26M-150.4%
2019$38.25M+105.2%
2018$-731.97M-15.8%
2017$-631.84M-11.6%
2016$-566.06M-